President Trump is now up 328% on this March stock investment

President Donald Trump – or his investing team – made thousands of stock trades throughout 2026, many of which recorded returns that were as rapid as they were impressive . By press time on October 15, a March purchase of the pharmaceutical and biotechnology company Moderna (NASDAQ: MRNA ) has emerged as one of his most lucrative investments. Specifically, at the time of President Trump’s earliest known MRNA stock buy – March 2, 2026 – the equity was changing hands at $52.85, while at the October 14 closing bell, it was 328.19% higher at $226.30. With the commander-in-chief purchasing up to $50,000 worth of Moderna shares, he might have seen his initial position rise as much as $164,095 to $214,095.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to Finbold.